- Home
- BIOA vs YDES Comparison
BIOA vs YDES Comparison
Compare BIOA & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BIOA | YDES |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.0M | 543.0M |
| IPO Year | 2024 | 2024 |
Fundamental Metrics
Financial Performance| Metric | BIOA | YDES |
|---|---|---|
| Price | $7.11 | $7.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $51.50 | N/A |
| AVG Volume (30 Days) | 621.6K | ★ 689.3K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,995,000.00 | N/A |
| Revenue This Year | $720.93 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.05 | $1.70 |
| 52 Week High | $25.96 | $22.00 |
Technical Indicators
Market Signals| Indicator | BIOA | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 28.10 | 75.89 |
| Support Level | N/A | $1.99 |
| Resistance Level | $8.53 | $9.11 |
| Average True Range (ATR) | 0.48 | 0.86 |
| MACD | 0.10 | 0.38 |
| Stochastic Oscillator | 7.11 | 94.16 |
Price Performance
Historical ComparisonAbout BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.